Andre-Jacques Auberton-Herve - 09 Jun 2023 Form 4 Insider Report for Bionik Laboratories Corp.

Role
Director
Signature
/s/ Andre-Jacques Auberton-Herve
Issuer symbol
BNKL on OTC
Transactions as of
09 Jun 2023
Net transactions value
+$390,000
Form type
4
Filing time
21 Jun 2023, 10:55:37 UTC
Previous filing
28 Feb 2022
Next filing
21 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock Purchase $390,000 +650,000 +238% $0.6000 923,160 09 Jun 2023 Shares held through Star SCI F1
holding BNKL Common Stock 10,693 09 Jun 2023 Shares held through 4A Consulting and Engineering
holding BNKL Common Stock 95,149 09 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person acquired the shares of common stock in lieu of cash payment of an aggregate of $390,000 in accrued and unpaid fees relating to reporting person's services as Chairman of the Board of the Issuer.